Unintended consequences of glucagon-like peptide-1 receptor agonists medications in children and adolescents: A call to action-Reference-Cited by-同舟云学术

Unintended consequences of glucagon-like peptide-1 receptor agonists medications in children and adolescents: A call to action

Published:2023 Issue:1 Volume:7 Page:
ISSN:2059-8661
Container-title:Journal of Clinical and Translational Science
language:en
Short-container-title:J. Clin. Trans. Sci.

Author:

Cooper Dan M.^ORCID,Rothstein Mark A.,Amin Alpesh,Hirsch Jan D.,Cooper Emma

Publisher

Cambridge University Press (CUP)

Subject

General Medicine

Reference30 articles.

1. Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial

2. Female Athlete Triad and Its Components: Toward Improved Screening and Management

3. Efficacy and Safety of Oral Small Molecule Glucagon-Like Peptide 1 Receptor Agonist Danuglipron for Glycemic Control Among Patients With Type 2 Diabetes

4. 23. Luthra S. Kaiser Health News on PBS. 2017. Why pediatric dosage forms may be more expensive than adult. Available from: https://www.pbs.org/newshour/health/kid-friendly-medications-can-expensive-parents. Accessed July 22, 2023.

5. 12. Youth Risk Behavior Surveillance — United States, 2011 [Internet]. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/ss6104a1.htm#Tab107. Accessed July 19, 2023.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti‐Obesity Medication in the Management of Children and Adolescents With Obesity: Recent Developments and Research Gaps;Clinical Endocrinology;2024-09-11

2. Practice Patterns of Glucagon-Like Peptide-1 Agonist Use Among Pediatric Bariatric Surgeons: A National Survey;Journal of Surgical Research;2024-09

3. Pharmacotherapy of Weight‐loss and Obesity with a Focus on GLP 1‐Receptor Agonists;The Journal of Clinical Pharmacology;2024-06-26

4. Dispensing of Glucagon-Like Peptide-1 Receptor Agonists to Adolescents and Young Adults, 2020-2023;JAMA;2024-06-18

5. Real‐world use of glucagon‐like peptide‐1 receptor agonists in youth with type 2 diabetes is associated with short‐term improvements in HbA1c;Diabetes, Obesity and Metabolism;2024-01-16